Literature DB >> 12761383

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles.

Mayla Hsu1, Jie Zhang, Mike Flint, Carine Logvinoff, Cecilia Cheng-Mayer, Charles M Rice, Jane A McKeating.   

Abstract

HIV pseudotypes bearing native hepatitis C virus (HCV) glycoproteins (strain H and Con1) are infectious for the human hepatoma cell lines Huh-7 and PLC/PR5. Infectivity depends on coexpression of both E1 and E2 glycoproteins, is pH-dependent, and can be neutralized by mAbs mapping to amino acids 412-447 within E2. Cell-surface expression of one or all of the candidate receptor molecules (CD81, low-density lipoprotein receptor, scavenger receptor class B type 1, and dendritic cell-specific intercellular adhesion molecule 3 grabbing nonintegrin) failed to confer permissivity to HIV-HCV pseudotype infection. However, HIV-HCV pseudotype infectivity was inhibited by a recombinant soluble form of CD81 and a mAb specific for CD81, suggesting that CD81 may be a component of a receptor complex.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761383      PMCID: PMC165865          DOI: 10.1073/pnas.0832180100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  Folding, assembly and subcellular localization of hepatitis C virus glycoproteins.

Authors:  J Dubuisson
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

Review 2.  Biogenesis of hepatitis C virus envelope glycoproteins.

Authors:  Anne Op De Beeck; Laurence Cocquerel; Jean Dubuisson
Journal:  J Gen Virol       Date:  2001-11       Impact factor: 3.891

3.  Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor.

Authors:  S Wünschmann; J D Medh; D Klinzmann; W N Schmidt; J T Stapleton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  In vivo adaptation of SHIV(SF162): chimeric virus expressing a NSI, CCR5-specific envelope protein.

Authors:  R C Tan; J M Harouse; A Gettie; C Cheng-Mayer
Journal:  J Med Primatol       Date:  1999 Aug-Oct       Impact factor: 0.667

5.  Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.

Authors:  V Agnello; G Abel; M Elfahal; G B Knight; Q X Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

6.  The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis.

Authors:  E R Quinn; C H Chan; K G Hadlock; S K Foung; M Flint; S Levy
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

7.  Characterization of pseudotype VSV possessing HCV envelope proteins.

Authors:  Y Matsuura; H Tani; K Suzuki; T Kimura-Someya; R Suzuki; H Aizaki; K Ishii; K Moriishi; C S Robison; M A Whitt; T Miyamura
Journal:  Virology       Date:  2001-08-01       Impact factor: 3.616

8.  Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein.

Authors:  M Flint; J M Thomas; C M Maidens; C Shotton; S Levy; W S Barclay; J A McKeating
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.

Authors:  A Higginbottom; E R Quinn; C C Kuo; M Flint; L H Wilson; E Bianchi; A Nicosia; P N Monk; J A McKeating; S Levy
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

10.  Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.

Authors:  Sabine Wellnitz; Bettina Klumpp; Heidi Barth; Susumu Ito; Erik Depla; Jean Dubuisson; Hubert E Blum; Thomas F Baumert
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

View more
  361 in total

1.  Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry.

Authors:  Graham Simmons; Jacqueline D Reeves; Andrew J Rennekamp; Sean M Amberg; Andrew J Piefer; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

2.  Divergent quasispecies evolution in de novo hepatitis C virus infection associated with bone marrow transplantation.

Authors:  Weihua Wang; Jianguo Lin; De Tan; Yanjuan Xu; Elizabeth M Brunt; Xiaofeng Fan; Adrian M Di Bisceglie
Journal:  Biochem Biophys Res Commun       Date:  2011-09-16       Impact factor: 3.575

3.  Regulation of host innate immunity by hepatitis C virus: crosstalk between hepatocyte and NK/DC.

Authors:  Sung-Jae Park; Young S Hahn
Journal:  Rev Infect       Date:  2010-07-01

4.  Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication Cycle.

Authors:  Shanshan He; Kelin Li; Billy Lin; Zongyi Hu; Jingbo Xiao; Xin Hu; Amy Q Wang; Xin Xu; Marc Ferrer; Noel Southall; Wei Zheng; Jeffrey Aubé; Frank J Schoenen; Juan J Marugan; T Jake Liang; Kevin J Frankowski
Journal:  J Med Chem       Date:  2017-07-13       Impact factor: 7.446

5.  Affinity maturation to improve human monoclonal antibody neutralization potency and breadth against hepatitis C virus.

Authors:  Yong Wang; Zhen-Yong Keck; Anasuya Saha; Jinming Xia; Fraser Conrad; Jianlong Lou; Michael Eckart; James D Marks; Steven K H Foung
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

6.  CD81-dependent binding of hepatitis C virus E1E2 heterodimers.

Authors:  Laurence Cocquerel; Chiung-Chi Kuo; Jean Dubuisson; Shoshana Levy
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein.

Authors:  Ania Owsianka; Alexander W Tarr; Vicky S Juttla; Dimitri Lavillette; Birke Bartosch; François-Loïc Cosset; Jonathan K Ball; Arvind H Patel
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication-competent virus and pseudoparticles.

Authors:  Lisa N Wasilewski; Stuart C Ray; Justin R Bailey
Journal:  J Gen Virol       Date:  2016-09-21       Impact factor: 3.891

9.  Long-term persistence of infection in chimpanzees inoculated with an infectious hepatitis C virus clone is associated with a decrease in the viral amino acid substitution rate and low levels of heterogeneity.

Authors:  Javier Fernandez; Deborah Taylor; Duncan R Morhardt; Kathleen Mihalik; Montserrat Puig; Charles M Rice; Stephen M Feinstone; Marian E Major
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization.

Authors:  Anne K Schwarz; Joe Grove; Ke Hu; Christopher J Mee; Peter Balfe; Jane A McKeating
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.